This is a Validated Antibody Database (VAD) review about Rhesus mon.. FAS, based on 20 published articles (read how Labome selects the articles), using FAS antibody in all methods. It is aimed to help Labome visitors find the most suited FAS antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FAS synonym: CD95; tumor necrosis factor receptor superfamily member 6; FASLG receptor; Fas (TNF receptor superfamily, member 6); Fas receptor CD95; apo-1 antigen; apoptosis-mediating surface antigen FAS

BioLegend
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; tbl s1
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (DX2)
  • flow cytometry; Rhesus monkey; loading ...; fig 3a
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on Rhesus monkey samples (fig 3a). J Virol (2019) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (fig 2a). Int J Infect Dis (2018) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (DX2)
  • flow cytometry; mouse; loading ...; fig s3f
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, BioLegend FAS antibody (BioLegend, 305622) was used in flow cytometry on mouse samples (fig s3f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend FAS antibody (Biolegend, 305607) was used in flow cytometry on human samples (fig 2a). Oncotarget (2017) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; 1:50; loading ...; fig s2
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples at 1:50 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (DX2)
  • flow cytometry; Rhesus monkey; loading ...; fig 4
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on Rhesus monkey samples (fig 4). PLoS Pathog (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...
BioLegend FAS antibody (BioLegend, Dx2) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 1c
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 1c). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2c
In order to characterize B cells and antibody repertoires from injection drug users, BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 2c). PLoS ONE (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; tbl 1
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; fig 9c
In order to identify a B cell-intrinsic mechanism by which IFN signaling promotes lupus pathogenesis, BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples (fig 9c). J Exp Med (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; loading ...; fig 2a
In order to characterize B and T cells from patients with thrombocytopenia, BioLegend FAS antibody (BioLegend, 305608) was used in flow cytometry on human samples (fig 2a). Haematologica (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; Rhesus monkey; fig 4
In order to assess the ability of HIV-1 envelope glycoprotein-specific broadly neutralizing monoclonal antibodies to suppress acute simian-human immunodeficiency virus replication in rhesus macaques, BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on Rhesus monkey samples (fig 4). J Virol (2016) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human
BioLegend FAS antibody (Biolegend, 305612) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (DX2)
  • flow cytometry; Rhesus monkey; fig 4
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on Rhesus monkey samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; fig 6
BioLegend FAS antibody (Biolegend, DX2) was used in flow cytometry on human samples (fig 6). Am J Hum Genet (2015) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human; 1:40
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples at 1:40. Nat Med (2014) ncbi
mouse monoclonal (DX2)
  • flow cytometry; human
BioLegend FAS antibody (BioLegend, DX2) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
Articles Reviewed
  1. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  2. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  3. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  4. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed publisher
  5. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  6. Ren J, Zhang X, Liu X, Fang C, Jiang S, June C, et al. A versatile system for rapid multiplex genome-edited CAR T cell generation. Oncotarget. 2017;8:17002-17011 pubmed publisher
  7. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  8. Berry N, Manoussaka M, Ham C, Ferguson D, Tudor H, Mattiuzzo G, et al. Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine. PLoS Pathog. 2016;12:e1006083 pubmed publisher
  9. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed publisher
  10. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  11. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  12. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  13. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed publisher
  14. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  15. Bolton D, Pegu A, Wang K, McGinnis K, Nason M, Foulds K, et al. Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs. J Virol. 2016;90:1321-32 pubmed publisher
  16. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  17. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  18. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher
  19. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed publisher
  20. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher